Advertisement
Singapore markets close in 3 hours 20 minutes
  • Straits Times Index

    3,305.27
    +32.55 (+0.99%)
     
  • Nikkei

    38,406.12
    +853.96 (+2.27%)
     
  • Hang Seng

    17,165.34
    +336.41 (+2.00%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Bitcoin USD

    66,728.34
    +133.80 (+0.20%)
     
  • CMC Crypto 200

    1,440.27
    +25.51 (+1.80%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Gold

    2,340.40
    -1.70 (-0.07%)
     
  • Crude Oil

    83.54
    +0.18 (+0.22%)
     
  • 10-Yr Bond

    4.5980
    -0.0520 (-1.12%)
     
  • FTSE Bursa Malaysia

    1,568.59
    +6.95 (+0.45%)
     
  • Jakarta Composite Index

    7,168.54
    +57.73 (+0.81%)
     
  • PSE Index

    6,585.39
    +78.59 (+1.21%)
     

Is AbbVie About To Get A New Blockbuster Drug?

Is AbbVie About To Get A New Blockbuster Drug?

AbbVie recently applied for FDA approval of its advanced Parkinson's disease drug candidate. This could be huge considering it's set to lose market exclusivity of Humira.